Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.
about
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesThe pathogenicity of cytomegalovirus.Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoproteinInnate immunity defines the capacity of antiviral T cells to limit persistent infectionGamma interferon-dependent clearance of cytomegalovirus infection in salivary glandsDevelopment of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replicationCytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging.Prevention of autoimmune lysis by T cells with specificity for a heat shock protein by antisense oligonucleotide treatment.DNA immunization confers protection against murine cytomegalovirus infection.Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host.Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferonRecognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2.Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartmentSusceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target.The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose.
P2860
Q24645843-92944A0A-7FB5-432B-AFD0-4363F50101C1Q33697113-9BE61F9F-6AF4-4DF5-814A-03C4B620D146Q33782029-2ABDE864-ACE0-4D20-B8D4-96AC96063E67Q33802461-44422420-4F97-46D9-8FD9-32C02B80F133Q33834018-13EF6E6E-244B-49FE-A9AE-F22D2FFE65BFQ33902354-787B5614-B67F-43DB-8DD8-042E1C6E8081Q33930607-99BBFF63-19BB-436C-9DFB-D07DD1247F4EQ34338715-7B45A787-581B-43E7-A361-F52EC88BDC50Q34390499-AA7CF322-3736-4B6C-86D1-415D3FD1C443Q35368485-E9C66D29-7B8C-428A-AAAC-6212CD396F5CQ35872388-775C437F-668A-42C8-9DC5-2B93D834DA3FQ35872401-E2EAACC1-0E7F-4807-944E-1CB948308904Q36355018-31DD35EF-457C-440D-A118-820CBBD84704Q36356034-F6C78DB9-DF58-49F9-9D82-0BAF09DC6050Q36402602-A9697D1E-B7CB-4028-AB9A-7CFD7C607E86Q36594211-1EE355B2-C0ED-4C51-A18E-38E399FADBBCQ36640468-25A26D6D-9778-4021-873E-92DB4FDE1FD5Q36655786-6DEB1C67-5D48-4404-BE2E-5EE8B14228AEQ36695109-376CF5FF-1B8F-4BBE-A1AC-08B7D8CC6CEDQ36793382-2FF3DC99-A8AB-49DA-8BE1-7E106A0C8EACQ37452497-E10AA93F-D087-4EBC-989D-FFBA9214B390Q40067052-27A3B36E-6ACE-410D-BD63-C00BF727D891Q40127728-21647FD2-E38E-4EF6-84CC-9DAB0522A5B2Q40130785-6D0F5690-4EC4-40DA-B594-9348CCD3E0CCQ40339745-B4DAEB5B-A85D-4444-89EC-F31769E8FF65Q41606905-1D248500-B1D6-49CD-B443-98DA0292561BQ42801965-87D9EC2D-DE0E-4BDD-AE3E-7BB326033698Q47549093-357FF435-8DD0-492B-BBE1-F35D94D2FFB6
P2860
Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@en
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@nl
type
label
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@en
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@nl
prefLabel
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@en
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@nl
P2093
P2860
P356
P1476
Cytolytic T lymphocyte recogni ...... by recombinant vaccinia virus.
@en
P2093
Bertholet C
Koszinowski UH
P2860
P304
P356
10.1084/JEM.166.3.668
P407
P577
1987-09-01T00:00:00Z